DAWNDAY ONE BIOPHARMACEUTICALS I
CUSIP 23954D109 · common stock
No tracked investor reported shares of DAY ONE BIOPHARMACEUTICALS I (DAWN) for Q2 2026. 4 investors sold out this quarter, including Perceptive Advisors.
Holders · Q2 2026
0
New holders
0
Value held
$0
Quarter-end price (est.)
—
Investors holding DAWN · Q2 2026
No tracked investor reported shares this quarter.
Sold out this quarter
| Investor | Prior weight | Prior shares | Prior value | Change |
|---|---|---|---|---|
| Perceptive Advisors | 0.74% | 1,755,799 | $37.6M | EXIT |
| George Soros | 0.36% | 1,539,100 | $33M | EXIT |
| Adar1 Capital Management | 0.06% | 49,923 | $1.1M | EXIT |
| Ken Fisher | 0.00% | 43,698 | $936.9K | EXIT |